Amy Welsh
Corporate Officer/Principal en AGILE THERAPEUTICS, INC. .
Fortuna: 4 874 $ al 31/05/2024
Cargos activos de Amy Welsh
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AGILE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2022 | - |
| Ventas & Marketing | 01/05/2020 | 01/11/2022 |
Historial de carrera de Amy Welsh
Antiguos cargos conocidos de Amy Welsh.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ANTARES PHARMA, INC. | Ventas & Marketing | 01/06/2017 | 01/05/2020 |
Formación de Amy Welsh.
| LaSalle University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Sales & Marketing | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Amy Welsh
- Experiencia
